Artificial Tears, Tear Lipids and Tear Film Dynamics

PHASE4CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

January 30, 2023

Primary Completion Date

September 30, 2023

Study Completion Date

January 30, 2024

Conditions
Dry Eye
Interventions
DRUG

Systane Complete PF

3 month use, 4 times daily, of Systane Complete PF, a lipid-based, preservative-free artificial tear product

DRUG

Refresh Relieva PF

3 month use, 4 times daily, of Refresh Relieva PF, a non-lipid-based, preservative-free artificial tear product

DRUG

Refresh Optive Mega-3 PF

3 month use, 4 times daily, of Refresh Optive Mega-3 PF, a lipid-based, preservative-free artificial tear product

DRUG

CVS Health Lubricant Eye Drop (PG 0.6%)

3 month use, 4 times daily, of CVS Health Lubricant Eye Drop (PG 0.6%), a lipid-based, preserved artificial tear product

Trial Locations (1)

94720-2020

Clinical Research Center, School of Optometry, University of California, Berkeley, Berkeley

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Alcon Research

INDUSTRY

lead

University of California, Berkeley

OTHER

NCT05705518 - Artificial Tears, Tear Lipids and Tear Film Dynamics | Biotech Hunter | Biotech Hunter